OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Epigenetic modulators of thyroid cancer
Sandra Rodríguez‐Rodero, Elías Delgado, Lucía Díaz-Naya, et al.
Endocrinología Diabetes y Nutrición (2017) Vol. 64, Iss. 1, pp. 44-56
Closed Access | Times Cited: 24
Sandra Rodríguez‐Rodero, Elías Delgado, Lucía Díaz-Naya, et al.
Endocrinología Diabetes y Nutrición (2017) Vol. 64, Iss. 1, pp. 44-56
Closed Access | Times Cited: 24
Showing 24 citing articles:
HDAC inhibitors as antifibrotic drugs in cardiac and pulmonary fibrosis
Xing Lyu, Min Hu, Jieting Peng, et al.
Therapeutic Advances in Chronic Disease (2019) Vol. 10
Open Access | Times Cited: 108
Xing Lyu, Min Hu, Jieting Peng, et al.
Therapeutic Advances in Chronic Disease (2019) Vol. 10
Open Access | Times Cited: 108
Cancer Stem Cells in Thyroid Tumors: From the Origin to Metastasis
Veronica Veschi, Francesco Verona, Melania Lo Iacono, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 35
Veronica Veschi, Francesco Verona, Melania Lo Iacono, et al.
Frontiers in Endocrinology (2020) Vol. 11
Open Access | Times Cited: 35
Advances and challenges in thyroid cancer: The interplay of genetic modulators, targeted therapies, and AI-driven approaches
Srinjan Bhattacharya, Rahul Kumar Mahato, Satwinder Singh, et al.
Life Sciences (2023) Vol. 332, pp. 122110-122110
Open Access | Times Cited: 12
Srinjan Bhattacharya, Rahul Kumar Mahato, Satwinder Singh, et al.
Life Sciences (2023) Vol. 332, pp. 122110-122110
Open Access | Times Cited: 12
Meta-analysis of promoter methylation in eight tumor-suppressor genes and its association with the risk of thyroid cancer
Fatemeh Khatami, Bagher Larijani, Ramin Heshmat, et al.
PLoS ONE (2017) Vol. 12, Iss. 9, pp. e0184892-e0184892
Open Access | Times Cited: 37
Fatemeh Khatami, Bagher Larijani, Ramin Heshmat, et al.
PLoS ONE (2017) Vol. 12, Iss. 9, pp. e0184892-e0184892
Open Access | Times Cited: 37
Epigenetic signatures in cardiac fibrosis, special emphasis on DNA methylation and histone modification
Hui Tao, Zhengyu Song, Xuansheng Ding, et al.
Heart Failure Reviews (2018) Vol. 23, Iss. 5, pp. 789-799
Closed Access | Times Cited: 33
Hui Tao, Zhengyu Song, Xuansheng Ding, et al.
Heart Failure Reviews (2018) Vol. 23, Iss. 5, pp. 789-799
Closed Access | Times Cited: 33
BRAF mutation, selected miRNAs and genes expression in primary papillary thyroid carcinomas and local lymph node metastases
David Kalfeřt, Marie Ludvíková, Martin Pešta, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155319-155319
Closed Access | Times Cited: 3
David Kalfeřt, Marie Ludvíková, Martin Pešta, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155319-155319
Closed Access | Times Cited: 3
Research Progress on Epigenetics of Diabetic Cardiomyopathy in Type 2 Diabetes
Jianxin Deng, Yunxiu Liao, Liu Jian-pin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18
Jianxin Deng, Yunxiu Liao, Liu Jian-pin, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 18
Multi-Omics and Management of Follicular Carcinoma of the Thyroid
Thifhelimbilu Emmanuel Luvhengo, I Bombil, Arian Mokhtari, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1217-1217
Open Access | Times Cited: 7
Thifhelimbilu Emmanuel Luvhengo, I Bombil, Arian Mokhtari, et al.
Biomedicines (2023) Vol. 11, Iss. 4, pp. 1217-1217
Open Access | Times Cited: 7
RETRACTED ARTICLE: Long noncoding RNA LINC00520 accelerates progression of papillary thyroid carcinoma by serving as a competing endogenous RNA of microRNA-577 to increase Sphk2 expression
Yu Sun, Tiefeng Shi, Yanfei Ma, et al.
Cell Cycle (2020) Vol. 19, Iss. 7, pp. 787-800
Open Access | Times Cited: 18
Yu Sun, Tiefeng Shi, Yanfei Ma, et al.
Cell Cycle (2020) Vol. 19, Iss. 7, pp. 787-800
Open Access | Times Cited: 18
Organochlorine pesticides and epigenetic alterations in thyroid tumors
Fouzieh Salimi, Gholamreza Asadikaram, Mohammad Reza Ashrafi, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Fouzieh Salimi, Gholamreza Asadikaram, Mohammad Reza Ashrafi, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 6
Epigenetic Effects of Dietary Trace Elements
Andy T. Y. Lau, Heng Wee Tan, Yan‐Ming Xu
Current Pharmacology Reports (2017) Vol. 3, Iss. 5, pp. 232-241
Closed Access | Times Cited: 17
Andy T. Y. Lau, Heng Wee Tan, Yan‐Ming Xu
Current Pharmacology Reports (2017) Vol. 3, Iss. 5, pp. 232-241
Closed Access | Times Cited: 17
NOL4 is Downregulated and Hyper-Methylated in Papillary Thyroid Carcinoma Suggesting Its Role as a Tumor Suppressor Gene
Sara Sheikholeslami, Fereidoun Azizi, Asghar Ghasemi, et al.
International Journal of Endocrinology and Metabolism (2020) Vol. 18, Iss. 4
Open Access | Times Cited: 14
Sara Sheikholeslami, Fereidoun Azizi, Asghar Ghasemi, et al.
International Journal of Endocrinology and Metabolism (2020) Vol. 18, Iss. 4
Open Access | Times Cited: 14
The expression of HDAC9 and P300 in papillary thyroid carcinoma cell line
Hatice Özışık, Berrin Özdil, Aslı Süner, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154385-154385
Closed Access | Times Cited: 3
Hatice Özışık, Berrin Özdil, Aslı Süner, et al.
Pathology - Research and Practice (2023) Vol. 243, pp. 154385-154385
Closed Access | Times Cited: 3
Investigation of promoter methylation of FSCN1 gene and FSCN1 protein expression in differentiated thyroid carcinomas
Mojdeh Mahdiannasser, Vahid Haghpanah, Elia Damavandi, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 3, pp. 2161-2169
Closed Access | Times Cited: 6
Mojdeh Mahdiannasser, Vahid Haghpanah, Elia Damavandi, et al.
Molecular Biology Reports (2020) Vol. 47, Iss. 3, pp. 2161-2169
Closed Access | Times Cited: 6
Tendencias epidemiológicas del cáncer de tiroides en la zona centro de Ecuador en el periodo 2012-2016
Jorge Isaac Sánchez Miño, Zenia Batista Castro, María de la Caridad García Barceló, et al.
Mediciencias UTA (Impresa)/Mediciencias UTA (En línea) (2021) Vol. 5, Iss. 3, pp. 58-58
Open Access | Times Cited: 6
Jorge Isaac Sánchez Miño, Zenia Batista Castro, María de la Caridad García Barceló, et al.
Mediciencias UTA (Impresa)/Mediciencias UTA (En línea) (2021) Vol. 5, Iss. 3, pp. 58-58
Open Access | Times Cited: 6
The Epigenetic Modification of SLC5A8 in Papillary Thyroid Carcinoma and its Effects on Clinic-Pathological Features
Sara Sheikholeslami, Fereidoun Azizi, Asghar Ghasemi, et al.
Iranian Journal of Public Health (2022)
Open Access | Times Cited: 3
Sara Sheikholeslami, Fereidoun Azizi, Asghar Ghasemi, et al.
Iranian Journal of Public Health (2022)
Open Access | Times Cited: 3
The impact of iodine deficiency exposure on thyroid nodule cytology and pathology – A single institute, case-control study
Hadar Rotem Betito, Hen Chaushu, Yonatan Lahav, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104022-104022
Closed Access | Times Cited: 1
Hadar Rotem Betito, Hen Chaushu, Yonatan Lahav, et al.
American Journal of Otolaryngology (2023) Vol. 45, Iss. 1, pp. 104022-104022
Closed Access | Times Cited: 1
Liquid Biopsy as a Method for Minimally Invasive Diagnosis of Thyroid Cancer
Tagir I. Rakhmatullin, Mark Jain, L. М. Samokhodskaya, et al.
Journal of clinical practice (2023) Vol. 14, Iss. 3, pp. 69-79
Open Access | Times Cited: 1
Tagir I. Rakhmatullin, Mark Jain, L. М. Samokhodskaya, et al.
Journal of clinical practice (2023) Vol. 14, Iss. 3, pp. 69-79
Open Access | Times Cited: 1
Modern concepts of the molecular pathogenesis of thyroid cancer
A. A. Mikhailova, А В Шестаков, K. A. Chubakova, et al.
Advances in molecular oncology (2021) Vol. 8, Iss. 2, pp. 8-22
Open Access | Times Cited: 2
A. A. Mikhailova, А В Шестаков, K. A. Chubakova, et al.
Advances in molecular oncology (2021) Vol. 8, Iss. 2, pp. 8-22
Open Access | Times Cited: 2
Thyroid Nodules in Diagnostic Pathology: From Classic Concepts to Innovations
Ilze Fridrihsone, Ilze Štrumfa, Boriss Štrumfs, et al.
InTech eBooks (2018)
Open Access | Times Cited: 1
Ilze Fridrihsone, Ilze Štrumfa, Boriss Štrumfs, et al.
InTech eBooks (2018)
Open Access | Times Cited: 1
Familial Clinical Heterogeneity of Medullary Thyroid Cancer with Germline RET S891A Protooncogene Mutation: 7-Year Follow-up with Successful Sorafenib Treatment
Sirmen Kızılcan Çetin, Zeynep Şıklar, Elif Özsu, et al.
Journal of Clinical Research in Pediatric Endocrinology (2023)
Open Access
Sirmen Kızılcan Çetin, Zeynep Şıklar, Elif Özsu, et al.
Journal of Clinical Research in Pediatric Endocrinology (2023)
Open Access
An interpretable multiple kernel learning approach for the discovery of integrative cancer subtypes.
Nora K. Speicher, Nico Pfeifer
arXiv (Cornell University) (2018)
Closed Access
Nora K. Speicher, Nico Pfeifer
arXiv (Cornell University) (2018)
Closed Access
Liquid Biopsy in Patients with Thyroid Carcinoma
Ilze Fridrihsone, Arnis Āboliņš, Andrejs Vanags, et al.
IntechOpen eBooks (2019)
Open Access
Ilze Fridrihsone, Arnis Āboliņš, Andrejs Vanags, et al.
IntechOpen eBooks (2019)
Open Access
WHAT IS EPIGENETIC CHANGE AND WHAT DO WE KNOW ABOUT ITS IMPACT ON MOLECULAR PATHOLOGIC MECHANISMS OF THE DISEASES?
Kemal Kürşat Bozkurt, Ayça Tan, Onur Ertunç, et al.
SDÜ Tıp Fakültesi Dergisi (2022) Vol. 29, Iss. 2, pp. 273-283
Open Access
Kemal Kürşat Bozkurt, Ayça Tan, Onur Ertunç, et al.
SDÜ Tıp Fakültesi Dergisi (2022) Vol. 29, Iss. 2, pp. 273-283
Open Access
